Literature DB >> 3501502

Long-term remission of immune neutropenia after treatment with high-dose intravenous 7S-immunoglobulin.

K Mann1, A Fateh-Moghadam, A Pfeiffer, W Samtleben, G Meyer, R Bartl, M Wiesneth.   

Abstract

In a 61-year-old woman recurrent bacterial infections were caused by immune neutropenia which was resistant to high-dose cortisone and plasmapheresis. However, high-dose intravenous 7S-immunoglobulin therapy (30 g for 6 days) induced a long-term remission for 35 months. This treatment modality is safe and should be used as a first-line agent.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3501502     DOI： 10.1007/BF01717834

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  15 in total

1.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

2.  Effect of intravenous immunoglobulin in immune thrombocytopenia.

Authors:  A Salama; C Mueller-Eckhardt; V Kiefel
Journal:  Lancet       Date:  1983-07-23       Impact factor: 79.321

3.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura.

Authors:  R E Schmidt; U Budde; G Schäfer; I Stroehmann
Journal:  Lancet       Date:  1981-08-29       Impact factor: 79.321

4.  Possible mechanisms of intravenous immunoglobulin treatment in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  P Imbach; T W Jungi
Journal:  Blut       Date:  1983-03

5.  Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

Authors:  J Fehr; V Hofmann; U Kappeler
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

6.  Idiopathic combined immunocytopenia.

Authors:  M Wiesneth; H Pflieger; N Frickhofen; H Heimpel
Journal:  Br J Haematol       Date:  1985-10       Impact factor: 6.998

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Autoimmune thrombocytopenia acquired from an allogeneic bone-marrow graft.

Authors:  R M Minchinton; A H Waters; J Kendra; A J Barrett
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

9.  High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood.

Authors:  P Imbach; S Barandun; V d'Apuzzo; C Baumgartner; A Hirt; A Morell; E Rossi; M Schöni; M Vest; H P Wagner
Journal:  Lancet       Date:  1981-06-06       Impact factor: 79.321

10.  A cooperative clinical trial of high-dose immunoglobulin therapy in 177 cases of idiopathic thrombocytopenic purpura.

Authors:  H Uchino; K Yasunaga; J Akatsuka
Journal:  Thromb Haemost       Date:  1984-04-30       Impact factor: 5.249
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.